• Factor II (Prothrombin) Mutation
  • Oncotype DX, Breast Cancer
  • Epstein-Barr Virus (EBV) VCA, IgM
  • Hypertrophic Cardiomyopathy Gene Mutation Panel, NGS
  • Poly A Binding Protein Nuclear 1Gene (PABPN1) Mutation Analysis
  • BDX-XL2, EarlyCDT®-Lung, Blood Test for Early Detection of Lung Cancer
  • G-protein gated Inwardly Rectifying K+ channel 1 (GIRK1) Genotyping
  • Sporothrix Antibody, Spinal Fluid
  • Tuberculosis Cell Mediated Immunity Antigen Response (QuantiFERON®-TB Gold ) Test
  • Varicella Zoster Virus (VZV) Antigen, DFA
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Neurofibromatosis Type 2 (NF2) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Neurofibromatosis Type 2 (NF2) Gene Mutation Analysis
Medical Test

Turnaround Time
Access to Neurofibromatosis Type 2 (NF2) Gene Mutation Analysis is restricted.
Loading...